Related references
Note: Only part of the references are listed.Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab
Yasmin Abaza et al.
BLOOD (2017)
Varying responses of PML-RARA with different genetic mutations to arsenic trioxide
Jiangying Liu et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Autologous transplant remains the preferred therapy for relapsed APL in CR2
C. Ganzel et al.
BONE MARROW TRANSPLANTATION (2016)
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia
S. Ganesan et al.
LEUKEMIA (2016)
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Alan K. Burnett et al.
LANCET ONCOLOGY (2015)
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
Harry J. Iland et al.
LANCET HAEMATOLOGY (2015)
Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance
Ezhilarasi Chendamarai et al.
PLOS ONE (2015)
Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
Hong-Hu Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy
Ezhilarasi Chendamarai et al.
BLOOD (2012)
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
Giuseppe Avvisati et al.
BLOOD (2011)
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Miguel A. Sanz et al.
BLOOD (2010)
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco et al.
BLOOD (2010)
Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide-Based Regimen
Rajasekar Thirugnanam et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
Treatment of newly diagnosed acute promyelocytic leukemia (APL):: a comparison of French-Belgian-Swiss and PETHEMA results
Lionel Ades et al.
BLOOD (2008)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
Molecular pathogenesis of acute promyelocytic leukaemia and APL variants
A Sirulnik et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2003)
Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors
G Avvisati et al.
SEMINARS IN HEMATOLOGY (2001)
Share Paper
